Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Etomidate

Rebound effect in the form of increased cortisol level

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cherian ET, et al. Etomidate - an Under Utilized but Safe and Efficacious Drug to Treat Acute Severe Cushing's Syndrome- Case Reports of Ectopic ACTH Syndrome from Neuroendocrine Malignancies. Journal of the Endocrine Society 4 (Suppl. 1): A699 abstr. MON-902, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1381 [abstract] Cherian ET, et al. Etomidate - an Under Utilized but Safe and Efficacious Drug to Treat Acute Severe Cushing's Syndrome- Case Reports of Ectopic ACTH Syndrome from Neuroendocrine Malignancies. Journal of the Endocrine Society 4 (Suppl. 1): A699 abstr. MON-902, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1381 [abstract]
Metadaten
Titel
Etomidate
Rebound effect in the form of increased cortisol level
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54481-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Tofersen

Case report

Methotrexate